Sins of omission - Cancer research without informed consent

New England Journal of Medicine

Volumn 351, Issue 7, 2004, Pages 628-630

  Lerner, Barron H ^a  

^a University of Columbia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL; CANCER IMMUNOLOGY; CANCER RESEARCH; CHRONIC DISEASE; DOCTOR PATIENT RELATION; GERMANY; HUMAN; HUMAN EXPERIMENT; HUMAN RIGHTS; INFORMED CONSENT; INJECTION; MEDICAL ETHICS; PRIORITY JOURNAL; RESPONSIBILITY; REVIEW; BIOMEDICAL AND BEHAVIORAL RESEARCH; ETHICS; HISTORY; LEGAL ASPECT; MEDICAL RESEARCH; NEOPLASM; NOTE; ONCOLOGY;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

BIOMEDICAL RESEARCH; ETHICS, MEDICAL; HISTORY, 20TH CENTURY; HUMAN EXPERIMENTATION; HUMANS; INFORMED CONSENT; MEDICAL ONCOLOGY; NEOPLASMS;

EID: 3943089869     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMp048108     Document Type: Review

References (5)

1. Katz J. Experimentation with human beings: the authority of the investigator, subject, professions, and state in the human experimentation process. New York: Russell Sage Foundation, 1972:9-65.
2. Langer E. Human experimentation: cancer studies at Sloan-Kettering stir public debate on medical ethics. Science 1964;143:551-3.
3. Preminger BA. The case of Chester M. Southam: research ethics and the limits of professional responsibility. Pharos Alpha Omega Alpha Honor Med Soc 2002;65(2):4-9.
4. Beecher HK. Ethics and clinical research. N Engl J Med 1966;274:1354-60.
5. Drazen JM, Koski G. To protect those who serve. N Engl J Med 2000;343:1643-5.